Halozyme Sparks With Elektrofi Acquisition, Expanding Partnering Options

 
• By Alaric DeArment
  
Two people shaking hands
Halozyme is acquiring Elektrofi for $750m upfront and up to three $50m milestone payments. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business